82
Lichtenthaler FW, Immel S (1996) Towards understanding formation and stability of cyclodextrin
inclusion complexes: computation and visualization of their molecular lipophilicity patterns.
Starch/Stärke 48:145–154
Lincoln SF, Easton CJ (1998) Chapter 14: inclusion complexes of the cyclodextrins. In: Dumitriu
S (ed) Polysaccharides: structural diversity and functional versatility. Marcel Dekker, Inc,
New York, pp 473–521
Lindner K, Saenger W (1978) β-cyclodextrine dodecahydrate: crowing of water molecules within
a hydrophobic cavity. Angew Chem Int Ed 17:694–695
Lipkowitz KB (1998) Applications of computational chemistry to the study of cyclodextrins.
Chem Rev 98:1829–1873
Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, Dietschy JM (2009) Reversal of defective
lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration
in the npc1−/− mouse. Proc Natl Acad Sci U S A 106:2377–2382. https://doi.org/10.1073/
pnas.0810895106
Loftsson T, Brewster ME (1996) Pharmaceutical applications of cyclodextrins.1. Drug solubilization and stabilization. J Pharm Sci 85:1017–1025. https://doi.org/10.1021/js950534b
Loftsson T, Brewster ME (2010) Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol 62:1607–1621. https://doi.
org/10.1111/j.2042-7158.2010.01030.x
Loftsson T, Brewster ME (2012) Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci 101:3019–3032. https://doi.org/10.1002/jps.23077
Loftsson T, Duchêne D (2007) Cyclodextrins and their pharmaceutical applications: historical perspectives. Int J Pharm 329:1–11. https://doi.org/10.1016/j.ijpharm.2006.10.044
Loftsson T, Stefánsson E (1997) Effect of cyclodextrins on topical drug delivery to the eye. Drug
Dev Ind Pharm 23:473–481. https://doi.org/10.3109/03639049709148496
Loftsson T, Stefánsson E (2017) Cyclodextrins and topical drug delivery to the anterior and posterior
segments of the eye. Int J Pharm 531:413–423. https://doi.org/10.1016/j.ijpharm.2017.04.010
Loftsson T, Másson M, Brewster ME (2004) Self-association of cyclodextrins and cyclodextrin
complexes. J Pharm Sci 93:1091–1099. https://doi.org/10.1002/jps.20047
Loftsson T, Jarho P, Másson M, Järvinen T (2005) Cyclodextrins in drug delivery. Expert Opin
Drug Deliv 2:335–351. https://doi.org/10.1517/17425247.2.1.335
Luda MP, Zanetti M (2019) Cyclodextrins and cyclodextrin derivatives as green char promoters in
flame retardants formulations for polymeric materials. A review. Polymers 11:664. https://doi.
org/10.3390/polym11040664
Lüttringhaus A, Cramer F, Prinzbach H, Henglein FM (1958) Cyclisationen von langkettigen dithiolen. Versuche zur darstellung sich umfassender ringe mit hilfe von einschlußverbindungen.
Liebigs Ann Chem 613:185–198. https://doi.org/10.1002/jlac.19586130120
Macaev F, Boldescu V (2015) Cyclodextrins in asymmetric and stereospecific synthesis. Symmetry
Basel 7:1699–1720. https://doi.org/10.3390/sym7041699
Madrid F, Ballesteros R, Lacorte S, Villaverde J, Morillo E (2019) Extraction of PAHS from
an aged creosote-polluted soil by cyclodextrins and rhamnolipids. Side effects on removal
and availability of potentially toxic elements. Sci Total Environ 635:384–392. https://doi.
org/10.1016/j.scitotenv.2018.10.316
Maeda Y, Motoyama K, Nishiyama R, Higashi T, Onodera R, Hakamura H, Takeo T, Nakagata
H, Yamada Y, Ishitsuka Y, Kondo Y, Irie T, Era T, Arima H (2019) In vivo efficacy and safety
evaluation of lactosyl-β-cyclodextrin as a therapeutic agent for hepatomegaly in Niemann-pick
type C disease. Nano 9:802. https://doi.org/10.3390/nano9050802
Mahmud ST, Wilson LD (2016) Synthesis and characterization of surface-modified mesoporous silica materials with beta-cyclodextrin. Cogent Chem 2:1132984. https://doi.org/10.108
0/23312009.2015.1132984
Malanga M, Szemán J, Fenyvesi E, Puskas I, Csabai K, Gyemant G, Fenyvesi F, Szente L
(2016) “Back to the future”: a new look at hydroxypropyl beta-cyclodextrins. J Phamr Sci
105:2921–2931. https://doi.org/10.1016/j.xphs.2016.04.034
N. Morin-Crini et al.
Lichtenthaler FW, Immel S (1996) Towards understanding formation and stability of cyclodextrin
inclusion complexes: computation and visualization of their molecular lipophilicity patterns.
Starch/Stärke 48:145–154
Lincoln SF, Easton CJ (1998) Chapter 14: inclusion complexes of the cyclodextrins. In: Dumitriu
S (ed) Polysaccharides: structural diversity and functional versatility. Marcel Dekker, Inc,
New York, pp 473–521
Lindner K, Saenger W (1978) β-cyclodextrine dodecahydrate: crowing of water molecules within
a hydrophobic cavity. Angew Chem Int Ed 17:694–695
Lipkowitz KB (1998) Applications of computational chemistry to the study of cyclodextrins.
Chem Rev 98:1829–1873
Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, Dietschy JM (2009) Reversal of defective
lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration
in the npc1−/− mouse. Proc Natl Acad Sci U S A 106:2377–2382. https://doi.org/10.1073/
pnas.0810895106
Loftsson T, Brewster ME (1996) Pharmaceutical applications of cyclodextrins.1. Drug solubilization and stabilization. J Pharm Sci 85:1017–1025. https://doi.org/10.1021/js950534b
Loftsson T, Brewster ME (2010) Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol 62:1607–1621. https://doi.
org/10.1111/j.2042-7158.2010.01030.x
Loftsson T, Brewster ME (2012) Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci 101:3019–3032. https://doi.org/10.1002/jps.23077
Loftsson T, Duchêne D (2007) Cyclodextrins and their pharmaceutical applications: historical perspectives. Int J Pharm 329:1–11. https://doi.org/10.1016/j.ijpharm.2006.10.044
Loftsson T, Stefánsson E (1997) Effect of cyclodextrins on topical drug delivery to the eye. Drug
Dev Ind Pharm 23:473–481. https://doi.org/10.3109/03639049709148496
Loftsson T, Stefánsson E (2017) Cyclodextrins and topical drug delivery to the anterior and posterior
segments of the eye. Int J Pharm 531:413–423. https://doi.org/10.1016/j.ijpharm.2017.04.010
Loftsson T, Másson M, Brewster ME (2004) Self-association of cyclodextrins and cyclodextrin
complexes. J Pharm Sci 93:1091–1099. https://doi.org/10.1002/jps.20047
Loftsson T, Jarho P, Másson M, Järvinen T (2005) Cyclodextrins in drug delivery. Expert Opin
Drug Deliv 2:335–351. https://doi.org/10.1517/17425247.2.1.335
Luda MP, Zanetti M (2019) Cyclodextrins and cyclodextrin derivatives as green char promoters in
flame retardants formulations for polymeric materials. A review. Polymers 11:664. https://doi.
org/10.3390/polym11040664
Lüttringhaus A, Cramer F, Prinzbach H, Henglein FM (1958) Cyclisationen von langkettigen dithiolen. Versuche zur darstellung sich umfassender ringe mit hilfe von einschlußverbindungen.
Liebigs Ann Chem 613:185–198. https://doi.org/10.1002/jlac.19586130120
Macaev F, Boldescu V (2015) Cyclodextrins in asymmetric and stereospecific synthesis. Symmetry
Basel 7:1699–1720. https://doi.org/10.3390/sym7041699
Madrid F, Ballesteros R, Lacorte S, Villaverde J, Morillo E (2019) Extraction of PAHS from
an aged creosote-polluted soil by cyclodextrins and rhamnolipids. Side effects on removal
and availability of potentially toxic elements. Sci Total Environ 635:384–392. https://doi.
org/10.1016/j.scitotenv.2018.10.316
Maeda Y, Motoyama K, Nishiyama R, Higashi T, Onodera R, Hakamura H, Takeo T, Nakagata
H, Yamada Y, Ishitsuka Y, Kondo Y, Irie T, Era T, Arima H (2019) In vivo efficacy and safety
evaluation of lactosyl-β-cyclodextrin as a therapeutic agent for hepatomegaly in Niemann-pick
type C disease. Nano 9:802. https://doi.org/10.3390/nano9050802
Mahmud ST, Wilson LD (2016) Synthesis and characterization of surface-modified mesoporous silica materials with beta-cyclodextrin. Cogent Chem 2:1132984. https://doi.org/10.108
0/23312009.2015.1132984
Malanga M, Szemán J, Fenyvesi E, Puskas I, Csabai K, Gyemant G, Fenyvesi F, Szente L
(2016) “Back to the future”: a new look at hydroxypropyl beta-cyclodextrins. J Phamr Sci
105:2921–2931. https://doi.org/10.1016/j.xphs.2016.04.034
N. Morin-Crini et al.